
Publication
Strategic asset search and evaluation in biopharma
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
This is an extract of our article in the GAR’s The Middle Eastern and African Arbitration Review 2023. The whole publication is available here.
This article outlines some of the legal concepts faced by investors and African states involved in large energy projects when a sudden change in the legal and economic context arises, and the disputes around these concepts. It also gives insight into two trending issues for energy projects in Africa that could give rise to contractual renegotiations and arbitrations in the years to come.
Publication
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright US LLP 2025